{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:30:05Z","timestamp":1793089805757,"version":"4.5.0"},"reference-count":32,"publisher":"Tech Science Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2022,5,4]]},"abstract":"<jats:p>This study was directed to deepen the effects of nutrient shortage on BCR\/Abl<jats:sub>protein<\/jats:sub> expression and signaling in chronic myeloid leukemia (CML) cells. The backbone of the study was cell culture in medium lacking glucose, the consumption of which we had previously shown to\n drive BCR\/Abl<jats:sub>protein<\/jats:sub> suppression, and glutamine, the other main nutrient besides glucose. In this context, we focused on the role of lactate, the main by-product of glucose metabolism under conditions of rapid cell growth, in particular as a modulator of the maintenance of CML stem\/progenitor\n cell potential, a crucial determinant of disease course and relapse of disease. The results obtained indicated that lactate is a powerful surrogate of glucose to prevent the suppression of BCR\/Abl signaling and is therefore capable to maintain BCR\/Abl-dependent CML stem\/progenitor cell potential.\n A number of metabolism-related functional and phenotypical features of CML cells were also determined. Among these, we focused on the effect of lactate on oxygen consumption rate, the dependence of this effect on the cell surface lactate carrier MCT-1, and the relationship of the lactate effect\n to pyruvate and to the activity of mitochondrial pyruvate carrier.<\/jats:p>","DOI":"10.3727\/096504022x16442289212164","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T01:06:26Z","timestamp":1644282386000},"page":"33-46","source":"Crossref","is-referenced-by-count":5,"title":["Lactate Maintains BCR\/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction"],"prefix":"10.32604","volume":"29","author":[{"given":"Angela","family":"Silvano","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Menegazzi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Peppicelli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mancini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Biagioni","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tubita","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazia","family":"Tusa","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ruzzolini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lulli","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Rovida","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persio","family":"Dello Sbarba","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences Mario Serio, Careggi Hospital, Universit degli Studi di FirenzeFlorenceItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","reference":[{"issue":"3","key":"b1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"b2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","article-title":"Leukemia stem cells: The root of chronic myeloid leukemia","volume":"6","year":"2015","journal-title":"Protein Cell"},{"issue":"12","key":"b3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: Stemming the tide of persistence","volume":"129","year":"2017","journal-title":"Blood"},{"issue":"5","key":"b4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2016-10-745588","article-title":"Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine","volume":"130","year":"2017","journal-title":"Blood"},{"issue":"7","key":"b5","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V82.7.2031.2031","article-title":"The role of hypoxia in the maintenance of hematopoietic stem cells","volume":"82","year":"1993","journal-title":"Blood"},{"issue":"4","key":"b6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.leu.2401744","article-title":"The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability","volume":"14","year":"2000","journal-title":"Leukemia"},{"issue":"1","key":"b7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0301-472X(01)00765-2","article-title":"Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells","volume":"30","year":"2002","journal-title":"Exp Hematol."},{"issue":"7","key":"b8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.leu.2404224","article-title":"Hypoxia suppresses BCR\/Abl and selects imatinib-insensitive progenitors within clonal CML populations","volume":"20","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"b9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3324\/haematol.2010.029082","article-title":"Glucose availability in hypoxia regulates the selection of chronic myeloid leukaemia progenitor subsets with different resistance to imatinib-mesylate","volume":"96","year":"2011","journal-title":"Haematologica"},{"issue":"20","key":"b10","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.4161\/15384101.2014.964107","article-title":"The metabolically modulated stem cell niche: A dynamic scenario regulating cancer cell phenotype and resistance to therapy","volume":"13","year":"2014","journal-title":"Cell Cycle"},{"issue":"51","key":"b11","doi-asserted-by":"crossref","first-page":"84810","DOI":"10.18632\/oncotarget.13319","article-title":"Different BCR\/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"b12","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia-inducible factor-1\u03b1, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","year":"2002","journal-title":"Blood"},{"issue":"11","key":"b13","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","year":"2012","journal-title":"Blood"},{"issue":"12","key":"b14","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","year":"2008","journal-title":"J Clin Invest."},{"issue":"3","key":"b15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.radonc.2009.06.025","article-title":"Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells","volume":"92","year":"2009","journal-title":"Radiother Oncol."},{"issue":"15","key":"b16","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00018-017-2496-y","article-title":"The acidic microenvironment as a possible niche of dormant tumor cells","volume":"74","year":"2017","journal-title":"Cell Mol Life Sci."},{"key":"b17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","article-title":"Metabolic interactions in the tumor microenvironment","volume":"27","year":"2017","journal-title":"Trends Cell Biol."},{"key":"b18","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.2174\/1381612811319300006","article-title":"The Culture-Repopulating Ability assays and incubation in low oxygen: A simple way to test drugs on leukemia stem or progenitor cells","volume":"19","year":"2013","journal-title":"Curr Pharm Des."},{"key":"b19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-4011-0_7","article-title":"The Culture Repopulation Ability (CRA) assay and incubation in low oxygen to test antileukemic drugs on imatinib-resistant CML stem-like cells","volume":"1465","year":"2016","journal-title":"Methods Mol Biol."},{"issue":"5","key":"b20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1179\/1973947813Y.0000000087","article-title":"Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells","volume":"25","year":"2013","journal-title":"J Chemother."},{"issue":"8","key":"b21","first-page":"990","article-title":"Labeling mitochondria with MitoTracker dyes","volume":"2011","year":"2011","journal-title":"Cold Spring Harb Protoc."},{"issue":"7","key":"b22","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2005-03-1103","article-title":"In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML","volume":"106","year":"2005","journal-title":"Blood"},{"issue":"4","key":"b23","first-page":"1611","article-title":"Monocarboxylic acid transport","volume":"3","year":"2013","journal-title":"Compr Physiol."},{"issue":"2","key":"b24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: A metabolic driver in the tumour landscape","volume":"44","year":"2019","journal-title":"Trends Biochem Sci."},{"issue":"4","key":"b25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/CBM-160336","article-title":"Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments","volume":"19","year":"2017","journal-title":"Cancer Biomark."},{"issue":"17","key":"b26","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.3390\/cancers13174372","article-title":"Glutamine availability controls BCR\/Abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem\/progenitor cell potential","volume":"13","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"b27","doi-asserted-by":"crossref","first-page":"e17008","DOI":"10.1371\/journal.pone.0017008","article-title":"Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia","volume":"6","year":"2011","journal-title":"PLoS-One"},{"issue":"Pt 1","key":"b28","first-page":"167","article-title":"Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH","volume":"333","year":"1998","journal-title":"Biochem J."},{"issue":"20","key":"b29","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1113\/JP270631","article-title":"Physiological increases in lactate inhibit intracellular calcium transients, acidify myocytes and decrease force in term pregnant rat myometrium","volume":"593","year":"2015","journal-title":"J Physiol."},{"issue":"1638","key":"b30","doi-asserted-by":"crossref","first-page":"20130099","DOI":"10.1098\/rstb.2013.0099","article-title":"The chemistry, physiology and pathology of pH in cancer","volume":"369","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"2","key":"b31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jcp.10408","article-title":"Reduction of intracellular pH inhibits constitutive expression of cyclooxygenase-2 in human colon cancer cells","volume":"198","year":"2004","journal-title":"J Cell Physiol."},{"key":"b32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1101\/sqb.2011.76.012856","article-title":"Cancer cell metabolism","volume":"76","year":"2011","journal-title":"Cold Spring Harb Symp Quant Biol."}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/uploads\/attached\/file\/20220620\/20220620162715_56629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T21:39:20Z","timestamp":1733521160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v29n1\/48451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,5,4]]}},"alternative-id":["0965-0407(20220504)29:1L.33;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504022x16442289212164","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,4]]}}}